Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 273-732-3 | CAS number: 69012-32-4 By-product of smelting of phosphate rock, silica and coke in manufacture of phosphorus.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicity to reproduction
Administrative data
- Endpoint:
- screening for reproductive / developmental toxicity
- Remarks:
- based on test type (migrated information)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 18 January 2010 - 16 July 2010
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: The study was conducted according to OECD guideline 422 and under GLP conditions.
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
- Report date:
- 2010
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 422 (Combined Repeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test)
- Deviations:
- no
- GLP compliance:
- yes
- Limit test:
- no
Test material
- Reference substance name:
- Slags, phosphorus-manufg.
- EC Number:
- 273-732-3
- EC Name:
- Slags, phosphorus-manufg.
- Cas Number:
- 69012-32-4
- Molecular formula:
- not applicable due to the multi constituent mineral structure of the substance
- IUPAC Name:
- aluminium(3+) heptacalcium magnesium(2+) λ²-iron(2+) disodium tris([(trioxidosilyl)oxy]silanetris(olate)) oxosilanebis(olate) hydroxysilanoylolate difluoride
- Details on test material:
- - Name of test material (as cited in study report): Phosphorous slag
- Physical state: Solid
- Stability under storage conditions: Stable
- Storage condition of test material: At room temperature in the dark
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: Crl:WI(Han)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories France, L'Arbrescle Cedex, France
- Age at study initiation: (P) approx. 11 wks
- Mean weight at study initiation: (P) Males: 330-338 g; Females: 210-218 g
- Housing:
Pre-mating: groups of 5/sex/cage
Mating: 1:1
Post-mating: males in groups of 5, females individually
- Diet: Ad libitum, pelleted rodent diet
- Water: Ad libitum, tap-water
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19.8-21.7
- Humidity (%): 21-69
- Air changes (per hr): approx. 15
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: 1% aqueous carboxymethyl cellulose
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
Formulations prepared daily within 6 hours prior to dosing and homogenized to a visually acceptable level.
VEHICLE
- Justification for use and choice of vehicle (if other than water): Based on trial formulations performed at the testing facility
- Amount of vehicle (if gavage): 5 ml/kg bw - Details on mating procedure:
- - M/F ratio per cage: 1:1
- Length of cohabitation:
- Proof of pregnancy: vaginal plug, sperm in vaginal smear or staging of the estrous cycle referred to as day 0 of pregnancy
- After 14 days of unsuccessful pairing mating was terminated
- After successful mating each pregnant female was caged: Individually - Analytical verification of doses or concentrations:
- no
- Details on analytical verification of doses or concentrations:
- No chemical analyses conducted, since no analytical method could be developed as the substance consisted of numerous components
- Duration of treatment / exposure:
- Males: 29 days (2 weeks prior to mating, during mating and up to termination)
Females: 43-56 days (2 weeks prior to mating, during mating, during pregnancy and at least 4 days of lactation) - Frequency of treatment:
- Daily
- Details on study schedule:
- - Age at mating of the mated animals in the study: approx. 13 weeks (P)
Doses / concentrations
- Remarks:
- Doses / Concentrations:
100, 300 and 1000 mg/kg bw/day
Basis:
actual ingested
- No. of animals per sex per dose:
- 10
- Control animals:
- yes, concurrent no treatment
- Details on study design:
- - Dose selection rationale: Based on results of a 10-day dose range finding study
- Rationale for animal assignment: Random according to body weight (with all animals within +/- 20% of the sex mean) - Positive control:
- Not required
Examinations
- Parental animals: Observations and examinations:
- CAGE SIDE OBSERVATIONS:
- Time schedule: At least twice daily
- Cage side observations: Mortality, viability
DETAILED CLINICAL OBSERVATIONS:
- Time schedule: Weekly
BODY WEIGHT:
- Time schedule for examinations: Weekly throughout the study and more frequent in females during preganancy (day 0, 4, 7, 11, 14, 17 and 20) and lactation (day 1 and 4)
FOOD CONSUMPTION:
- Food consumption for each animal determined and mean daily diet consumption: Recorded weekly, except for males and females which were housed together for mating. More frequent examination in females during preganancy (day 0, 4, 7, 11, 14, 17 and 20) and lactation (day 1 and 4)
WATER CONSUMPTION:
By subjective appraisal
REPRODUCTIVE PERFORMANCE:
- Precoital interval
- Reproductive indices
- Length of gestation
- Number of corpora lutea and implantations
- - Oestrous cyclicity (parental animals):
- Not included in this OECD test
- Sperm parameters (parental animals):
- Parameters examined in P male parental generations: testis weight, epididymis weight
- Litter observations:
- STANDARDISATION OF LITTERS
Not performed
PARAMETERS EXAMINED
The following parameters were examined in F1 offspring:
Number and sex of pups, stillbirths, live births, postnatal mortality, presence of gross anomalies, weight gain, physical abnormalities
GROSS EXAMINATION OF DEAD PUPS:
yes, for external abnormalities; possible cause of death was determined for pups born or found dead - Postmortem examinations (parental animals):
- SACRIFICE
- Male animals: All surviving animals, following completion of the mating period (min. of 28 days treatment).
- Maternal animals: All surviving animals. Females which delivered sacrificed on lactaction days 5-7, females that failed to deliver sacrificed on post-coitum day 26
GROSS NECROPSY
Gross necropsy consisted of external and internal examinations including the cervical, thoracic, and abdominal viscera of all animals.
ORGAN WEIGHTS
The tissues indicated below were weighed (from 5 selected animals/sex/group): Cervix, prostate gland, clitoral gland, seminal vesicles, coagulation gland, testes, epididymides, uterus, ovaries, vagina, preputial gland, all gross lesions
In all remaining males the epididymides and testes were weighed.
HISTOPATHOLOGY
Histopathology was performed for 5 selected animals/sex of group 1 and 4. The tissues indicated below were prepared for microscopic examination:
Adrenal glands, Peyer's patches (jejunum, ileum) if detectable, brain (cerebellum, mid-brain, cortex), pituitary gland, caecum, preputial gland, cervix, prostate gland, clitoral gland, rectum, colon, duodenum, sciatic nerve, epididymides, seminal vesicles including coagulating gland, eyes (with optic nerve (if detectable) and Harderian gland), skeletal muscle, female mammary gland area, spinal cord - cervical/midthoracic/lumbar, femur including joint, spleen, heart, sternum with bone marrow, ileum, stomach, jejunum, testes, kidneys, thymus, thyroid including parathyroid (if detectable), liver, trachea, lung, infused with formalin, urinary bladder, lymph nodes - mandibular/mesenteric, uterus, vagina, all gross lesions
Additional histopathology:
- Testes of 5 selected males of groups 1 and 4 to examine staging of spermatogenesis
- Reproductive organs (cervix, clitoral gland, coagulation gland, epididymides, ovaries, preputial gland, prostate gland, seminal vesicles, testes, uterus, and vagina) of all animals that failed to mate, conceive, sire or deliver healthy pups
- Stomach of 5 selected animals/sex of groups 2 and 3
- All gross lesions of all animals (all dose groups) were examined. - Postmortem examinations (offspring):
- SACRIFICE
- The F1 offspring not selected as parental animals and were sacrificed at approx. 4 days of age (on day 5, 6 or 7).
- These animals were subjected to postmortem macroscopic examination
GROSS NECROPSY
- Gross necropsy consisted of external examinations for abnormalities. The stomach was examined for the presence of milk. Defects or cause of death were evaluated if possible.
HISTOPATHOLOGY / ORGAN WEIGTHS
Not performed (but tissues were preserved for further examination when necessary) - Statistics:
- - Dunnett-test
- Steel-test
- Fisher Exact-test - Reproductive indices:
- - Mating index: No. of females mated / No. of females paired * 100
- Fertility index: No. of pregnant females / No. of females paired * 100
- Conception index: No. of pregnant females / No. of females mated * 100
- Gestation index: No. of females bearing liver pups / No. pregnant females * 100 - Offspring viability indices:
- - % live males at first litter check: No. of live male pups at first litter check / No. of live pups at first litter check * 100
- % live females at first litter check: No. of live female pups at first litter check / No. of live pups at first litter check * 100
- % of postnatal loss day 0-4 of lactation: No. of dead pups on day 4 of lactation / No. of live pups at first litter check * 100
- Viability index: No. of live pups on day 4 of lactation / No. of pups born alive * 100
Results and discussion
Results: P0 (first parental generation)
General toxicity (P0)
- Clinical signs:
- no effects observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Other effects:
- not examined
Reproductive function / performance (P0)
- Reproductive function: oestrous cycle:
- not examined
- Reproductive function: sperm measures:
- no effects observed
- Reproductive performance:
- no effects observed
Details on results (P0)
No toxicologically relevant clinical signs and no mortality occurred during the study period.
FOOD CONSUMPTION (PARENTAL ANIMALS)
No toxicologically significant effects on food consumption were observed, although food consumption was slight, but significantly, decreased during day 1-8 of treatment in females (pre-mating period). The effects were however minimal and no dose-related response was observed.
REPRODUCTIVE FUNCTION: SPERM MEASURES (PARENTAL ANIMALS)
No effects observed on testes and/or epididymides weight
REPRODUCTIVE PERFORMANCE (PARENTAL ANIMALS)
The mating, fertility and conception indices, precoital time, gestation length, number of corpora lutea and implantation sites were unaffected by treatment
ORGAN WEIGHTS (PARENTAL ANIMALS)
No toxicologically relevant changes were noted in absolute or relative organ weight as compared to the control group, although a signficant decrease in absolute and relative thyroid weight was observed in the low dose males. This effect was considered minimal and a dose-related response was absent.
GROSS PATHOLOGY (PARENTAL ANIMALS)
No toxicologically relevant or significant findings were noted in the macroscopic examination as compared to controls
HISTOPATHOLOGY (PARENTAL ANIMALS)
Microscopic changes were observed (but not significant) in the stomach of animals in each of the treatment groups, consisting of glandular inflammation, limiting ridge vacuolisation and limiting ridge squamous epithelial hyperplasia. These findings were only significant for males of the high dose group (with a positive trend). A slight dose-related trend could be identified over the treatment groups. The effects are expected to be caused by the high pH of the dosing formulations and therefore not considered of toxicological relevance.
No microscopic findings indicated infertility in the animals suspected thereof.
Effect levels (P0)
open allclose all
- Dose descriptor:
- NOAEL
- Remarks:
- parental
- Effect level:
- 1 000 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: No toxicologically relevant effects observed
- Dose descriptor:
- NOAEL
- Remarks:
- reproduction
- Effect level:
- 1 000 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: No toxicologically relevant effects observed
Results: F1 generation
General toxicity (F1)
- Clinical signs:
- no effects observed
- Mortality / viability:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Sexual maturation:
- no effects observed
- Organ weight findings including organ / body weight ratios:
- not examined
- Gross pathological findings:
- no effects observed
- Histopathological findings:
- not examined
Details on results (F1)
One pup of the control group and low dose group were found dead at the first litter check and missing on day 2 of lactation, but these deaths were not considered toxicologically relevant (no dose-related trend).
CLINICAL SIGNS (OFFSPRING)
No clinical signs were noted that were not within the range considered normal for pups of this age.
GROSS PATHOLOGY (OFFSPRING)
Absence of milk in the stomach was an incidental finding in the pup found dead at first litter check. The missing pup on day 2 was most likely cannabalised.
Effect levels (F1)
- Dose descriptor:
- NOAEL
- Remarks:
- developmental
- Generation:
- F1
- Effect level:
- 1 000 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: No toxicologically relevant effects observed
Overall reproductive toxicity
- Reproductive effects observed:
- not specified
Any other information on results incl. tables
RESULTS OF TEST | DOSING GROUPS | |||
Control | Low (100 mg/kg bw/day) | Medium (300 mg/kg bw/day) | High (1000 mg/kg bw/day) | |
ANALYSES | ||||
Actual concentration | Not determind due to complexity of the substance | |||
Stability | Stable up until temperatures of >500 °C | |||
Homogeneity | Visually acceptable | |||
pH of formulations | 6.44 | 11.03 | 11.25 | 11.33 |
TOXIC RESPONSE/EFFECTS BY DOSE LEVEL | ||||
PARENTAL DATA (P) | ||||
Number of animals (M/F) | 10/10 | 10/10 | 10/10 | 10/10 |
Mortality (numbers) | No mortality observed | No mortality observed | No mortality observed | No mortality observed |
Body weight | x | x | x | x |
Food consumption | x | *F: Slight decrease in absolute and relative food consumption during pre-mating phase (day 1-8) | *F: Slight decrease in absolute food consumption during pre-mating phase (day 1-8) | x |
Clinical signs | F: Effects on skin (alopecia; n=3, scales; n=3 and scabs; n=3) | F: Effects on skin (alopecia; n=3) | F: Effects on skin (alopecia; n=3) | x |
Organ weights | x | *M: Decrease in absolute and relative thyroid weight | x | x |
Macroscopy | F: Alopecia of skin (n=1) | F: Alopecia of skin (n=1), M: Foci in lungs (n=1) | F: Alopecia of skin (n=1), M: Foci in lungs (n=1), foci in stomach (n=3), discolouration of ileum (n=1), discolouration of adrenal gland (n=1) and enlarged mandibular lymph node (n=1) | F: Discolouration of clitoral gland (n=1), M: Foci in thymus (n=2) |
Microscopy | STOMACH: M: Minimal glandular inflammation (n=1) and minimal squamous epithelial hyperplasia (n=1) | STOMACH: F: Minimal squamous epithelial hyperplasia (n=1), M: Minimal (n=2) and slight (n=1) glandular inflammation, minimal vacuolisation (n=2) and minimal squamous epithelial hyperplasia (n=2) | STOMACH: F: Minimal squamous epithelial hyperplasia (n=1), M: Minimal (n=4) glandular inflammation, minimal vacuolisation (n=2) and minimal squamous epithelial hyperplasia (n=2) | STOMACH: F: Minimal squamous epithelial hyperplasia (n=3), M: Minimal glandular inflammation (n=5), minimal vacuolisation (n=2), minimal (n=2) and slight (n=1) squamous epithelial hyperplasia |
Effects on sperm (weight of testes/epididymides and staging of spermatogenesis) | All stages present | All stages present and no effect on organ weights | All stages present and no effect on organ weights | All stages present and no effect on organ weights |
Precoital interval (mean duration in days) | 2.4 | 5.1 | 3.0 | 2.8 |
Mating index (%) | 100 | 100 | 100 | 100 |
Fertility index (%) | 100 | 100 | 100 | 90 |
Conception index (%) | 100 | 100 | 100 | 90 |
Number of corpora lutea (mean numbers) | 17.5 | 14.6 | 15.7 | 14.0 |
No. of females with implantations (numbers) | 10 | 10 | 10 | 9 |
No. of implantations (mean numbers) | 13.6 | 12.8 | 12.6 | 13.3 |
Duration of gestation (mean in days) | 21.2 | 21.2 | 21.4 | 21.1 |
Gestation index (%) | 100 | 100 | 100 | 100 |
OFFSPRING TOXICITY (F1) | ||||
Number of litters | 10 | 10 | 10 | 9 |
Number found dead at first litter check | 1 | 0 | 0 | 0 |
Number of pups | 122 | 117 | 107 | 113 |
Litter size (mean) | 12.2 | 11.7 | 10.7 | 12.6 |
Sex ratio (M/F) | 0.46 | 0.46 | 0.50 | 0.54 |
Mean foetal weight (M+F in gram) | 6.1 | 6.1 | 6.5 | 6.0 |
Post natal survival PD0-4 (numbers) | 122 | 116 | 107 | 113 |
Viability index (%) | 100 | 99.1 | 100 | 100 |
Postnatal growth (BW gain PD0-4) | x | x | x | x |
Macroscopic observations | Dead pup: absence of milk in stomach | Missing pup: most likely cannabalised | x | x |
x = no effects (as compared to control group) | ||||
* = significant effect |
Applicant's summary and conclusion
- Conclusions:
- Under the condtions of this study, no toxicologically significant effects were observed in P or F1 as a result of a minimum of 28-day exposure to phosphorous slag. A NOAEL of 1000 mg/kg bw/day was therefore established for developmental, reproduction and parental toxicity.
- Executive summary:
An OECD 422 test was performed to study the (reproductive) effect of 28-day exposure to phosphorous slag in rats.
No treatment related clinical signs or mortality were noted. All other effects noted at different examinations were minimal and not considered of toxicological significance. Histopathological changes in the stomach of test article treated parental animals are expected to be caused by the high pH of the dosing formulations and not considered toxicologically based. No toxicologically meaningful effects on fertility, reproductive performance or development of the offspring were observed.
Under the condtions of this study, no toxicologically significant effects were observed in P or F1 as a result of a minimum of 28-day exposure to phosphorous slag. A NOAEL of 1000 mg/kg bw/day was therefore established for developmental, reproduction and parental toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.